# Topical Vitamin D3, Diclofenac or a Combination of Both to Treat Basal Cell Carcinoma

> **NCT01358045** · PHASE2 · COMPLETED · sponsor: **Maastricht University Medical Center** · enrollment: 128 (actual)

## Conditions studied

- Basal Cell Carcinoma

## Interventions

- **DRUG:** Diclofenac
- **DRUG:** Diclofenac + Calcitriol
- **DRUG:** Calcitriol

## Key facts

- **NCT ID:** NCT01358045
- **Lead sponsor:** Maastricht University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2013-02
- **Final completion:** 2013-05
- **Target enrollment:** 128 (ACTUAL)
- **Last updated:** 2015-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01358045

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01358045, "Topical Vitamin D3, Diclofenac or a Combination of Both to Treat Basal Cell Carcinoma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01358045. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*